These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 36470260)
1. Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors. Kim M; Lee C; Hong J; Kim J; Jeong JY; Park NJ; Kim JE; Park JY Cancer Res Treat; 2023 Apr; 55(2):429-441. PubMed ID: 36470260 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors. Martínez-Fernández P; Pose P; Dolz-Gaitón R; García A; Trigo-Sánchez I; Rodríguez-Zarco E; Garcia-Ruiz M; Barba I; Izquierdo-García M; Valero-Garcia J; Ruiz C; Lázaro M; Carbonell P; Gargallo P; Méndez C; Ríos-Martín JJ; Palmeiro-Uriach A; Camarasa-Lillo N; Forteza-Vila J; Calabria I J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33947144 [TBL] [Abstract][Full Text] [Related]
3. Validation of the Oncomine Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577 [TBL] [Abstract][Full Text] [Related]
5. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. Cheng DT; Mitchell TN; Zehir A; Shah RH; Benayed R; Syed A; Chandramohan R; Liu ZY; Won HH; Scott SN; Brannon AR; O'Reilly C; Sadowska J; Casanova J; Yannes A; Hechtman JF; Yao J; Song W; Ross DS; Oultache A; Dogan S; Borsu L; Hameed M; Nafa K; Arcila ME; Ladanyi M; Berger MF J Mol Diagn; 2015 May; 17(3):251-64. PubMed ID: 25801821 [TBL] [Abstract][Full Text] [Related]
6. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy. Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691 [TBL] [Abstract][Full Text] [Related]
7. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599 [TBL] [Abstract][Full Text] [Related]
8. Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel. Glodzik D; Selenica P; Rogge RA; Silverman IM; Mandelker D; Harris S; Zhao J; Zinda M; Veloso A; Malani N; Riaz N; Koehler M; Daber RD; Johnson V; Rimkunas V; Reis-Filho JS J Mol Diagn; 2023 May; 25(5):295-310. PubMed ID: 36944408 [TBL] [Abstract][Full Text] [Related]
9. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material. de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material. Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863 [TBL] [Abstract][Full Text] [Related]
11. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer. Ju S; Cui Z; Hong Y; Wang X; Mu W; Xie Z; Zeng X; Su L; Lin X; Zhang Z; Zhang Q; Song X; You S; Chen R; Chen W; Xu C; Zhao J Cancer; 2023 Aug; 129(15):2422-2430. PubMed ID: 37096747 [TBL] [Abstract][Full Text] [Related]
12. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours. Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059 [TBL] [Abstract][Full Text] [Related]
13. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing. Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646 [TBL] [Abstract][Full Text] [Related]
14. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies. Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745 [TBL] [Abstract][Full Text] [Related]
15. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection. Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714 [TBL] [Abstract][Full Text] [Related]
16. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice. Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127 [TBL] [Abstract][Full Text] [Related]
17. A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma. Shao D; Lin Y; Liu J; Wan L; Liu Z; Cheng S; Fei L; Deng R; Wang J; Chen X; Liu L; Gu X; Liang W; He P; Wang J; Ye M; He J Sci Rep; 2016 Mar; 6():22338. PubMed ID: 26936516 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors. Froyen G; Geerdens E; Berden S; Cruys B; Maes B Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626061 [TBL] [Abstract][Full Text] [Related]
19. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070 [TBL] [Abstract][Full Text] [Related]
20. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory. Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]